Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
Antiflammins are synthetic peptides with sequence homology to proteins inhibitory for phospholipase A2. The effects of antiflammins on chloride secretion induced by the calcium ionophore A23187, arachidonic acid (AA) and prostaglandin E2 (PGE2) were investigated in distal rabbit colonic mucosa mounted in Ussing-type chambers. 100 nM AF-2 (antiflammin 2, peptide HDMNKVLDL) fully prevented the increase in Isc, net chloride secretion, tissue PGE2 and second messenger cAMP induced by 5 microM A23187. AF-1 (antiflammin 1, peptide MQMKKVLDS) also inhibited, although to a lesser extent, the A23187-mediated increase in Isc. AF-2 inhibition began at doses of 100 nM (delta Isc -0.20 +/- 0.08, microEq h-1 cm-2, mean +/- S.E.M., N = 3) and was maximal at doses comprised between 200 and 250 nM (delta Isc -0.51 +/- 0.12, microEq h-1 cm-2, mean +/- S.E.M., N = 3). AF-2 also inhibited the increase in Isc and chloride secretion induced by the incubation with 10 microM AA and bradykinin but it was ineffective when tissues were stimulated with 10 microM PGE2. 100 nM AF-2 brought about an inhibition of the increase in AA-mediated increases in PGs and cAMP comparable to that of 10 microM of the cyclooxygenase inhibitor indomethacin. In vitro assay of colonic cyclooxygenase activity showed that 100 nM AF-2 and AF-1 inhibited cyclooxygenase activity (73 and approximately 30%, respectively), but they did not modify the in vitro activity of porcine phospholipase A2.(ABSTRACT TRUNCATED AT 250 WORDS)
Calderaro
V
V
Institute of Pharmacology and Toxicology, First Faculty of Medicine, University of Naples, Federico II, Italy.
Parrillo
C
C
Giovane
A
A
Greco
R
R
Matera
M G
MG
Berrino
L
L
Rossi
F
F
D000595:Amino Acid Sequence; D000818:Animals; D017302:Annexins / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D016718:Arachidonic Acid / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D000001:Calcimycin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002712:Chlorides / Q000378:metabolism*; D000242:Cyclic AMP / Q000096:biosynthesis; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000096:biosynthesis; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism; D008969:Molecular Sequence Data; D010455:Peptides / Q000494:pharmacology*; D010741:Phospholipases A / Q000032:analysis; D054467:Phospholipases A2; D011817:Rabbits
D017302:Annexins; D000893:Anti-Inflammatory Agents; D002712:Chlorides; D016861:Cyclooxygenase Inhibitors; D010455:Peptides; D016718:Arachidonic Acid; D000001:Calcimycin; D000242:Cyclic AMP; D010741:Phospholipases A; D054467:Phospholipases A2; D015232:Dinoprostone